Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Study of PX-866 and Docetaxel in Solid Tumors

ClinicalTrials.gov ID: NCT01204099

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01204099. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:32 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1/2 Study of PX-866 and Docetaxel in Patients With Solid Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 1: To determine the maximally tolerated dose (MTD) or recommended dose (RD) and any potential efficacy of PX-866 in combination with docetaxel in patients with solid tumors. Phase 2: To determine the antitumor activity and safety of PX-866 in combination with docetaxel versus docetaxel alone in patients with NSCLC or SCCHN.

Study identification

NCT ID
NCT01204099
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Cascadian Therapeutics Inc.
Industry
Enrollment
223 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
Dec 2013 (Actual)
Completion
Feb 2014 (Actual)
Last update posted
May 16, 2018

2010 – 2014

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Southwest Cancer Care Escondido California 92025 —
Bay Area Cancer Research Group, LLC Pleasant Hill California 94523 —
University of Colorado Cancer Center Aurora Colorado 80045 —
Eastern Colorado Health Care System - Denver VA Denver Colorado 80220 —
Cancer Center of Pasco-Pinellas Holiday Florida 34619 —
Cancer Center of Kansas Wichita Kansas 67214 —
John Hopkins University Baltimore Maryland 21231 —
Washington University St Louis Missouri 63110 —
New Mexico Cancer Care Alliance Albuquerque New Mexico 87131 —
Roswell Park Cancer Institute Buffalo New York 14263 —
New York Oncology, Hematology Latham New York 12110 —
Beth Israel Hospital New York New York 10003 —
New York University Medical Center New York New York 10016 —
Columbia University Medical Center New York New York 10032 —
Montefiore Medical Center The Bronx New York 10467 —
Northwest Cancer Specialists Tualatin Oregon 97062 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 —
Medical University of South Carolina Charleston South Carolina 29425 —
Texas Oncology - South Austin Austin Texas 78745 —
Mary Crowley Cancer Center Dallas Texas 75201 —
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
Oncology and Hematology Associates of SW Virginia, DBA Blue Ridge Cancer Care Christiansburg Virginia 24073 —
Virginia Cancer Specialists Fairfax Virginia 22031 —
Virginia Oncology Associates Newport News Virginia 23606 —
Columbia Basin Hematology & Oncology Kennewick Washington 99336 —
Medical Oncology Associates Spokane Washington 99208 —
Yakima Valley Memorial Hospital/North Star Lodge Yakima Washington 98902 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01204099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2018 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.